Monthly Archives: December 2009

Venture investors are warming to the idea of doing deals in “personalized medicine” – diagnostic tests, often based on genetics, that could improve outcomes and lower costs. But regulatory and reimbursement hurdles are the norm, not the exception. Nonetheless, some deals such as Highland Capital’s portfolio company Generation Health, appear very attractive. Continue reading →